TY - JOUR T1 - RAPID lung cancer diagnostic and care pathway from referral to treatment JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2020.2912 VL - 56 IS - suppl 64 SP - 2912 AU - Adnan Amir AU - Alison Spray AU - Nicola Haley AU - Katheryn Gracie AU - Alison Gill Y1 - 2020/09/07 UR - http://erj.ersjournals.com/content/56/suppl_64/2912.abstract N2 - Introduction: This was a pilot prospective study which compared RAPID lung cancer pathway with existing arrangements for diagnosis, staging and treatment of lung cancer.Aims: Early diagnosis and treatment of lung cancer improves survival. We compared RAPID lung cancer pathway with existing arrangements to reduce the hurdles in early diagnosis and provision of treatment to potential lung cancer patients. Early investigations identify non-cancer patients quicker.Methods: On existing pathway chest X-ray (CXR) is requested by general practitioner (GP) as a first line investigation on lung cancer suspicion. If CXR is reported as abnormal then radiology requests a CT thorax with urgent request for GP to refer to hospital after discussion with the patient. On RAPID pathway, abnormal X-ray report is highlighted to lung cancer coordinator who Organizes GP referral, speaks to patient directly and organizes them to attend hospital for CT thorax, Lung function test, Respiratory physician appointment and lung cancer specialist nurse review on the same day. We looked at both pathways to see the number of days it took from referral to investigations.Results: There was reduction in time over 6 months from GP referral to hospital appointment from a median of 12 days to 4 days on RAPID pathway. It also expedited the CT thorax from a median of 7 days to 4 days on RAPID pathway.Discussion: This study has shown that streamlining the pathway gives patients the opportunity to have access to appropriate services earlier. It also improves patient experience which was reflected by positive feedback provided by the patients on this pathway.It also reduced te number of visits to the hospitals by introducing the concept of "one stop clinic".FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 2912.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -